Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: A five-month multicentre Canadian study

Canadian Respiratory Journal

Volumn 10, Issue 8, 2003, Pages 427-434

  FitzGerald, J Mark ^a,h   Sears, Malcolm R ^b   Boulet, Louise Philippe ^c   Becker, Allan B ^d   McIvor, Andrew R ^e   Ernst, Pierre ^f   Smiljanic Georgijev, Natasha M ^g   Lee, Joanna S M ^g   Abdulla, R ⁱ   Achyuthan, G ⁱ   Amer, E ⁱ   Anthony, J ⁱ   Bailey, A ⁱ   Baltzan, M ⁱ   Begin, P ⁱ   Bergstrom, C ⁱ   Bishop, G ⁱ   Booth, W ⁱ   Brankston, E ⁱ   Brownoff, R ⁱ   Bukowskyj, M ⁱ   Carom, D ⁱ   Carrim, E ⁱ   Carswell, D J ⁱ   Cartier, A ⁱ   Chan, C K N ⁱ   Che, C ⁱ   Chow, W ⁱ   Dhar, A ⁱ   D'Ignazio, G ⁱ   Dionne, L ⁱ   Domingue, C ⁱ   Dowell, A ⁱ   Ellis, C ⁱ   Faiers, A ⁱ   Fay, D ⁱ   Fera, T A ⁱ   Fraser, F ⁱ   Gagnon, M ⁱ   Hart, R ⁱ   Henry, D ⁱ   Hirsch, A ⁱ   Homik, L A ⁱ   Houle, P A ⁱ   House, W P ⁱ   Jadd, J ⁱ   Jardin, F F ⁱ   Kanani, S ⁱ   Kanawaty, D S ⁱ   Kaplan, A ⁱ   Kapur, S ⁱ   Kelly, A ⁱ   Kelton, P ⁱ   Kim, J ⁱ   Kozak, J ⁱ   Kugler, P ⁱ   LaFreniere, M ⁱ   Larivee, P ⁱ   Laroche, C ⁱ   Lasko, B ⁱ   Laviolette, M ⁱ   Leclair, M ⁱ   Leung, A ⁱ   Leung, W ⁱ   Lewis, J ⁱ   Liu, F L ⁱ   Loader, K R ⁱ   MacDonald, J ⁱ   Marciniuk, D ⁱ   Mazza, G ⁱ   McLaughlin, W ⁱ   Mintz, S ⁱ   Papp, E ⁱ   Patel, P C ⁱ   Payton, K B ⁱ   Pinsky, N ⁱ   Prevost, P ⁱ   Redekopp, A ⁱ   Saunders, K ⁱ   Senior, R ⁱ   Siegel, I ⁱ   Sinclair, D ⁱ   Small, D ⁱ   Soowamber, M ⁱ   Stakiw, K ⁱ   Stollery, D ⁱ   St Pierre, C ⁱ   Taylor, G ⁱ   Tellier, G ⁱ   Tytus, R ⁱ   Winzer, W ⁱ   Zackon, H ⁱ   Ziter, P ⁱ   Zuberbuhler, P ⁱ   Jordana, Gloria ⁱ   Dakin, Paula ⁱ   Calmels, Sophia ⁱ   Kim, Tony ⁱ   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g ASTRAZENECA   (United Kingdom)

^h VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

ⁱ NONE

Author keywords

Adjustable dosing; Asthma; Budesonide; Exacerbation; Formeterol

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE; NEDOCROMIL SODIUM; SALBUTAMOL; TERBUTALINE; XANTHINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; EMERGENCY TREATMENT; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HUMAN; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 10744229972     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/298039     Document Type: Article

References (23)

1. Boulet L-P, Becker A, Bérube D, Beveridge R, Ernst P on behalf of the Canadian Asthma Consensus Group. Summary of recommendations from the Canadian Asthma Consensus Report. CMAJ 1999;161(Suppl 11):S1-12.
2. Boulet L-P, Bai TR, Becker A, et al. What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J 2001;8:5A-27A.
3. British Thoracic Society/Scottish Intercollegiate Guidelines Network (BTS/SIGN). British guidelines on the management of asthma. Thorax 2003;58(Suppl 1):1-94.
4. Global Initiative for Asthma (GINA). National Institutes of Health (NIH). National Heart, Lung, and Blood Institute (NHLBI). Global Strategy for Asthma Management and Prevention. Publication Number 02-3659. Bethesda: NIH/NHLBI, 2002.
5. Abramson MJ, Bailey MJ, Couper FJ, et al. Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med 2001;163:12-8.
6. Gibson PG, Powell H, Coughlan J, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003;CD001117.
7. Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101:457-63.
8. Ringdal N, Derom E, Wahlin-Boll E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. Respir Med 1998;92:1017-21.
9. Palmqvist M, Ibsen T, Mellen A, Lötvall J. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients. Am J Respir Crit Care Med 1999;160:244-9.
10. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive airways disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
11. National Heart, Lung, and Blood Institute. National Institutes of Health, World Health Organization. Global Initiative for Asthma. Pocket Guide for Asthma Management. Publication Number 97-4051A. Bethesda: NIH/NHLBI, 1997.
12. Ontario Ministry of Health. Schedule of Benefits - Physician Services Under The Health Insurance Act. Toronto: Queen's Printer for Ontario, 2002.
13. PPS Pharma Publication. Moncton: Total Pricing Systems Inc, 2003.
14. Ontario Ministry of Health. Ontario Drug Benefit Formulary/Comparative Drug Index, No 37. Toronto: Queen's Printer for Ontario, 2002.
15. Awadh Behbehani N, Grunfeld A, FitzGerald JM. Health care costs associated with acute asthma: A prospective economic analysis. Can Respir J 1999;6:521-5.
16. Department of Human Resources Development Canada. Employment Insurance Legislation. Ottawa: Government of Canada, 1997.
17. Barber JA, Thompson SG. Analysis of cost data in randomized trials: An application of the non-parametric bootstrap. Star Med 2000;19:3219-36.
18. Pauwels RA, Löfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-11.
19. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392-7.
20. Ställberg B, Olsson P, Jörgensen LA, Lindarck N, Ekström T. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int J Clin Pract 2003;57:656-61.
21. FitzGerald J, Lee J, Becker A, et al. A randomized controlled, multicentre study to compare double dose versus maintenance of dose of inhaled corticosteroids (ICS) during asthma exacerbations. Am J Respir Crit Care Med 2000;1(Suppl 61):A187. (Abst)
22. Aziz I, Wilson AM, Lipworth BJ. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults. Chest 2000;118:1049-58.
23. Turner MO, Taylor D, Bennett R, Fitzgerald JM. A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med 1998;157:540-6.